Caricamento...
Reassessment of Pioglitazone for Alzheimer’s Disease
Alzheimer’s disease is a quintessential ‘unmet medical need’, accounting for ∼65% of progressive cognitive impairment among the elderly, and 700,000 deaths in the United States in 2020. In 2019, the cost of caring for Alzheimer’s sufferers was $244B, not including the emotional and physical toll on...
Salvato in:
| Pubblicato in: | Front Neurosci |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8243371/ https://ncbi.nlm.nih.gov/pubmed/34220427 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnins.2021.666958 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|